Starling Oncology Warrant
STLNW
22 hedge funds and large institutions have $1.83M invested in Starling Oncology Warrant in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
550% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 2
201% more capital invested
Capital invested by funds: $610K → $1.83M (+$1.23M)
100% more funds holding
Funds holding: 11 → 22 (+11)
1.77% more ownership
Funds ownership: 1.44% → 3.22% (+1.8%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$175K |
| 2 |
KC
Kepos Capital
New York
|
+$156K |
| 3 |
Man Group
London,
United Kingdom
|
+$156K |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$144K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$103K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$46K |
| 2 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$38K |
| 3 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$16.4K |
STLNW Hedge Fund Activity: Q3 2020 in Review
22 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Warrant (STLNW) for Q3 2020, worth a combined $1.83M — up 201% from $610K a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new STLNW positions and 2 closed out — a net gain of 11 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $175K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $46K sold.
- 22 institutional investors held Starling Oncology Warrant (STLNW) as of Q3 2020, up from 11 in Q2 2020.
- Funds reported $1.83M of Starling Oncology Warrant stock for Q3 2020, up 201% quarter-over-quarter.
- 13 funds opened new Starling Oncology Warrant positions in Q3 2020 and 2 closed out, a net change of +11 holders.
- The largest Starling Oncology Warrant buyer in Q3 2020 was Glazer Capital LLC, an estimated $175K added.
- The largest Starling Oncology Warrant seller in Q3 2020 was Hudson Bay Capital Management, an estimated $46K sold.
Based on aggregated 13F filings for Q3 2020.